Trial
NCT00538980
Dasatinib in Polycythemia Vera
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Weill Medical College of Cornell University
Collaborators
Bristol-Myers Squibb
Condition
Polycythemia Vera
Intervention
Dasatinib
Why stopped
This study was terminated due to lack of efficacy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-20